Whereas MEK inhibition in control mice resulted in ∼24% reduction in tumor growth, ∼81% reduction was observed in Il-1r1−/− mice treated with MEKi (Fig. 8 A), clearly demonstrating that stromal IL-1 signals are important in promoting tolerance to MAPK inhibition in melanoma. Here, MAP2K7 is linked to melanoma.